Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Parsons

Showing results (411-420 of 424) with videos related to

Pageof 43
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Imidazopyridines: a novel class of hNav1.7 channel blockersClare London, Scott B Hoyt, William H Parsons, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Substituted biaryl pyrazoles as sodium channel blockersSriram Tyagarajan, Prasun K Chakravarty, Bishan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
JAMA Oncology|June 3, 2019
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 StudyThomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic painSriram Tyagarajan, Prasun K Chakravarty, Bishan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Benzazepinone Nav1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, Hyun Ok, et al.
Cellular Immunology|December 23, 1999
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channelsG C Koo, J T Blake, K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active siteScott M Sheehan, Hans-Juergen Mest, Brian M Watson, et al.
Biochemistry|July 28, 2004
A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain modelBirgit T Priest, Maria L Garcia, Richard E Middleton, et al.
The Journal of Clinical Investigation|September 6, 2007
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicityJeremy R Graff, Bruce W Konicek, Thomas M Vincent, et al.
Pageof 43

Showing results (411-420 of 424) with videos related to

Sort By:
Pageof 43
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Imidazopyridines: a novel class of hNav1.7 channel blockersClare London, Scott B Hoyt, William H Parsons, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Substituted biaryl pyrazoles as sodium channel blockersSriram Tyagarajan, Prasun K Chakravarty, Bishan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, David Gorin, et al.
JAMA Oncology|June 3, 2019
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 StudyThomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic painSriram Tyagarajan, Prasun K Chakravarty, Bishan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Benzazepinone Nav1.7 blockers: potential treatments for neuropathic painScott B Hoyt, Clare London, Hyun Ok, et al.
Cellular Immunology|December 23, 1999
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channelsG C Koo, J T Blake, K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active siteScott M Sheehan, Hans-Juergen Mest, Brian M Watson, et al.
Biochemistry|July 28, 2004
A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain modelBirgit T Priest, Maria L Garcia, Richard E Middleton, et al.
The Journal of Clinical Investigation|September 6, 2007
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicityJeremy R Graff, Bruce W Konicek, Thomas M Vincent, et al.
Pageof 43